
Current Issue
June 2023
Ding Dong: The Doctor Will See You (at Home) Now
Increasingly, patients are able to receive treatment for hematologic malignancies from the comfort of home.
Viewpoints
Editor’s Corner
The Often-Inexplicable Turns of a Career in Hematology
From the Desk Of... Videos
Education
You Make the Call
You Make the Call Readers' Response
Hematologica Obscura
Schnitzler Syndrome: A Monoclonal Gammopathy and Autoinflammatory Condition
Spotlight
Feature Articles
Ding Dong: The Doctor Will See You (at Home) Now
pASHions
Counting Her Chickens: Catherine C. Coombs, MD
News
Latest and Greatest
FDA Issues Full Ciinical Hold on SCD Treatment
Hemophilia A Drug Receives Approval
Pfizer to Buy Seagen for $43 Billion
FDA Extends BLA Review for Valoctocogene Roxaparvovec
FDA ODAC Votes in Favor of DLBCL Drug’s Clinical Benefit
Written in Blood
Concurrent Pembrolizumab and AVD as Frontline Therapy in Untreated cHL
Nivolumab Plus Brentuximab Vedotin an Option for Patients With Relapsed MGZL
Blood Advances in a Different Vein
Assumptions of Patient Perceptions Create Unnecessary Barriers to Palliative Care
More Structure, Rigor Needed in Peripheral Blood Smear Training
Diagnostic Tool Can Help Discern MDS Among Patients With Cytopenias
Literature Scan
Combined Pelabresib, Ruxolitinib Improved Splenomegaly in JAK Inhibitor Treatment-Naïve MF
Tool Using Time-Varying Biomarkers Predicts the Risk of Progression from Precursor Disease to MM
COVID-19 Bivalent Boosters Associated With Few Definitive Hematologic AEs
Preexisting T-Cell Landscape May Determine Bispecific TCE Therapy Response in MM
2022 ELN Genetic-Risk Stratification Does Not Predict Outcomes Better Than 2017 Stratification for Adults With AML
Society Pages
Remembering Amoz Chernoff (1923-2023)
Elizabeth Jaffee Awarded AACR-Margaret Foti Award
AMWA Awards Betty Pace 2023 Woman in Science Award
LLS Welcomes New President and CEO
LCRC Appoints New Deputy Director
ASH Directions
International Member Spotlight: Ahlam Nasser, MD